Two Madison-based biotechnology companies will present at separate investor conferences in New York City this week.
Chief Executive Officer Bob Palay of Cellular Dynamics International, Inc. (CDI) (Nasdaq: ICEL) is scheduled to present at the Leerink Swann Global Healthcare Conference, 3:30 p.m. Wednesday, Eastern Standard Time.
The live audio webcast and subsequent archived replay is available at http://investors.cellulardynamics.com/. CDI is a leading developer of stem cell technologies for in vitro drug development, stem cell banking and in vivo cellular therapeutic research.
Simon Pedder, acting president and CEO of Novelos Therapeutics, Inc. (OTCQX: NVLT) will present at the 16th Annual BIO CEO & Investor Conference 10:30 a.m. Tuesday, EST, at the Waldorf Astoria in New York City. Novelos is a biopharmaceutical company developing novel agents to detect, treat and monitor a broad spectrum of cancers. A live audio webcast of the presentation will be available at http://www.novelos.com/